Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  HER-2/neu peptide vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Vaccine Therapy in Treating Patients with Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab
Status: Enrolling by invitation
Phase: Phase II, Phase I
Type: Treatment
Age: Over 18
Trial IDs: 6304, NCI-2016-00895, NCT00194714
Start Over